Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1
  2. Abulwerdi,Fardokht; Xu, Wenbo; Ageeli, Abeer A.; Yonkunas, Michael J.; Arun, Gayatri; Nam, Hyeyeon; Schneekloth,Jay; Dayie, Theodore Kwaku; Spector, David; Baird, Nathan; Le Grice,Stuart
  3. ACS CHEMICAL BIOLOGY. 2019, Feb; 14(2): 223-235.
  1. 2.   DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer
  2. Chen, M.; Shabashvili, D.; Nawab, A.; Yang, S. X.; Dyer, L. M.; Brown, K. D.; Hollingshead, M.; Hunter, K. W.; Kaye, F. J.; Hochwald, S. N.; Marquez, V. E.; Steeg, P.; Zajac-Kaye, M.
  3. Molecular Cancer Therapeutics. 2012, Feb; 11(2): 370-382.
  1. 3.   Loss of Rad51c Leads to Embryonic Lethality and Modulation of Trp53-Dependent Tumorigenesis in Mice
  2. Kuznetsov, S. G.; Haines, D. C.; Martin, B. K.; Sharan, S. K.
  3. Cancer Research. 2009 69(3): 863-872.
  1. 4.   An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments
  2. Nam, J. S.; Terabe, M.; Mamura, M.; Kang, N. J.; Chae, H.; Stuelten, C.; Kohn, E.; Tang, B.; Sabzevari, H.; Anver, M. R.; Lawrence, S.; Danielpour, D.; Lonning, S.; Berzofsky, J. A.; Wakefield, L. M.
  3. Cancer Research. 2008 68(10): 3835-3843.
  1. 5.   Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models
  2. Varticovski, L.; Hollingshead, M. G.; Robles, A. I.; Wu, X. L.; Cherry, J.; Munroe, D. J.; Lukes, L.; Anver, M. R.; Carter, J. P.; Borgel, S. D.; Stotler, H.; Bonomi, C. A.; Nunez, N. P.; Hursting, S. D.; Qiao, W. H.; Deng, C. X. X.; Green, J. E.; Hunter, K. W.; Merlino, G.; Steeg, P. S.; Wakefield, L. M.; Barrett, J. C.
  3. Clinical Cancer Research. 2007, Apr; 13(7): 2168-2177.
  1. 6.   Parallel analysis of transcript and translation profiles: Identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications
  2. Yang, H. Y.; Yu, L. R.; Yi, M.; Lucas, D. A.; Lukes, L.; Lancaster, M.; Chan, K. C.; Issaq, H. J.; Stephens, R. M.; Conrads, T. P.; Veenstra, T. D.; Hunter, K. W.
  3. Journal of Proteome Research. 2006, Jul; 5(7): 1555-1567.
  1. 7.   Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase
  2. Mitchell, M. S.; Tozser, J.; Princler, G.; Lloyd, P. A.; Auth, A.; Derse, D.
  3. Journal of Biological Chemistry. 2006, FEB 17; 281(7): 3964-3971.
  1. 8.   Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh)
  2. Raafat, A.; Bargo, S.; Anver, M. R.; Callahan, R.
  3. Oncogene. 2004, DEC 16; 23(58): 9401-9407.
  1. 9.   Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis
  2. Yang, H. Y.; Rouse, J.; Lukes, L.; Lancaster, M.; Veenstra, T.; Zhou, M.; Shi, Y.; Park, Y. G.; Hunter, K.
  3. Clinical & Experimental Metastasis. 2004 21(8): 719-735.
  1. 10.   Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphornas
  2. Kim, R.; Trubetskoy, A.; Suzuki, T.; Jenkins, N. A.; Copeland, N. G.; Lenz, J.
  3. Journal of Virology. 2003 77(3): 2056-2062.
  1. 11.   Initiating oncogenic event determines gene-expression patterns of human breast cancer models
  2. Desai, K. V.; Xiao, N.; Wang, W.; Gangi, L.; Greene, J.; Powell, J. I.; Dickson, R.; Furth, P.; Hunter, K.; Kucherlapati, R.; Simon, R.; Liu, E. T.; Green, J. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(10): 6967-6972.
  1. 12.   Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P450 1A1, 1A2, and 1B1
  2. MacDonald, C. J.; Ciolino, H. P.; Yeh, G. C.
  3. Cancer Research. 2001 61(10): 3919-3924.
  1. 13.   A potential mechanism for fumonisin B-1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3 beta activity
  2. Ramljak, D.; Calvert, R. J.; Wiesenfeld, P. W.; Diwan, B. A.; Catipovic, B.; Marasas, W. F. O.; Victor, T. C.; Anderson, L. M.; Gelderblom, W. C. A.
  3. Carcinogenesis. 2000 21(8): 1537-1546.
  1. 14.   Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain
  2. Sei, S.; Yang, Q. E.; O'Neill, D.; Yoshimura, K.; Nagashima, K.; Mitsuya, H.
  3. Journal of Virology. 2000 74(10): 4621-4633.
  1. 15.   Cloning and characterization of Krct, a member of a novel subfamily of serine/threonine kinases
  2. Stairs, D. B.; Gardner, H. P.; Ha, S. I.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Chodosh, L. A.
  3. Human Molecular Genetics. 1998 7(13): 2157-2166.
  1. 16.   Cellular Targets of the Anti-Breast Cancer Agent Z-1,1-Dichloro-2,3-Diphenylcyclopropane - Type Ii Estrogen Binding Sites and Tubulin
  2. Terhaar, E.; Hamel, E.; Balachandran, R.; Day, B. W.
  3. Anticancer Research. 1997 17(3C): 1861-1869.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel